Search research articles
Contact Us
Filters
Showing results (121-130 of 166) with videos related to
Page
of 17
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
February 24, 2019
The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials
S Cascinu, D Poli, A Zaniboni, et al.
British Journal of Cancer
|
December 7, 2007
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation
S Cascinu, R Berardi, S Salvagni, et al.
Lancet (London, England)
|
November 10, 1998
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
P Rougier, E Van Cutsem, E Bajetta, et al.
British Journal of Cancer
|
February 14, 1998
Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II study
C Aschele, A Guglielmi, G L Frassineti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2003
Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients
V Chiarion-Sileni, P Del Bianco, G L De Salvo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 6, 1999
A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancer
S Cascinu, R R Silva, R Labianca, et al.
British Journal of Cancer
|
July 17, 1999
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu, R R Silva, S Barni, et al.
British Journal of Cancer
|
April 15, 2004
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu, M Scartozzi, R Labianca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 1997
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer
S Cascinu, R Labianca, P Alessandroni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 1, 1997
Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) study
S Cascinu, S Barni, R Labianca, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 166) with videos related to
Sort By:
Page
of 17
European Journal of Cancer (Oxford, England : 1990)
|
February 24, 2019
The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials
S Cascinu, D Poli, A Zaniboni, et al.
British Journal of Cancer
|
December 7, 2007
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation
S Cascinu, R Berardi, S Salvagni, et al.
Lancet (London, England)
|
November 10, 1998
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
P Rougier, E Van Cutsem, E Bajetta, et al.
British Journal of Cancer
|
February 14, 1998
Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II study
C Aschele, A Guglielmi, G L Frassineti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2003
Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients
V Chiarion-Sileni, P Del Bianco, G L De Salvo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 6, 1999
A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancer
S Cascinu, R R Silva, R Labianca, et al.
British Journal of Cancer
|
July 17, 1999
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu, R R Silva, S Barni, et al.
British Journal of Cancer
|
April 15, 2004
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu, M Scartozzi, R Labianca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 1997
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer
S Cascinu, R Labianca, P Alessandroni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 1, 1997
Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) study
S Cascinu, S Barni, R Labianca, et al.
Page
of 17